Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Insiders..

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Dec 12, 2022 10:38am

221 Views

Post# 35166009

RE:Insiders..

Adonis wrote: now i know why insiders didn't buy shares in thtx.. imposters..

Actually, there has been buying from insiders and only one small seller recently - the Chief Legal Counsel in July. Buying has been much more significant than selling by insiders but neither buying nor selling has been impressive. If insiders were aware of the info about TH-1902's trial pause, they did not sell on that info. So, I am not sure much can be taken away from the insiders behavior, but if anything, it was a slightly positive message.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security